Evidence map›Paper›PMID 36696335›Full record

ArticlePlastic and reconstructive surgery2023

A Personalized Opioid Prescription Model for Predicting Postoperative Discharge Opioid Needs.

Kevin K Zhang, Kevin M Blum, Jacqueline J Chu, Abeba Zewdu, Sarah Janse, Roman Skoracki, Jeffrey E Janis, Jenny C Barker

Abstract read
In one paragraph

Article in Plastic and reconstructive surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Suzetrigine: What Should Plastic Surgeons Know?Plastic and reconstructive surgery. Global open · 2026
    Article
  2. Article
  3. Use of Muscle Relaxants for Acute Postoperative Pain: A Practical Review.Plastic and reconstructive surgery. Global open · 2024
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kevin K ZhangFrom the Department of Plastic and Reconstructive Surgery.
Kevin M BlumCenter for Regenerative Medicine, Nationwide Children's Hospital.
Jacqueline J ChuFrom the Department of Plastic and Reconstructive Surgery.
Abeba ZewduFrom the Department of Plastic and Reconstructive Surgery.
Sarah JanseCenter for Biostatistics, Department of Biomedical Informatics, The Ohio State University Medical Center.
Roman SkorackiFrom the Department of Plastic and Reconstructive Surgery.
Jeffrey E JanisFrom the Department of Plastic and Reconstructive Surgery.
Jenny C BarkerFrom the Department of Plastic and Reconstructive Surgery.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Advanced Research Training in Immunology for Surgery Trainees (ARTIST)T32AI106704 · NIAID · OHIO STATE UNIVERSITY · PI GINNY L BUMGARDNER, Jon R Wisler · 2014 to 2026
$3.5M
Modulating the Host Response to Tissue Engineered Vascular GraftsF32HL144120 · NHLBI · OHIO STATE UNIVERSITY · PI BARKER, JENNY CATHRYN · 2019 to 2021
$103k
NCI NIH HHS P30 CA008748NHLBI NIH HHS F32 HL144120NIAID NIH HHS T32 AI106704
6 · The paper itself

Abstract

backgroundOpioid overprescribing after surgery is common. There is currently no universal predictive tool available to accurately anticipate postdischarge opioid need in a patient-specific manner. This study examined the efficacy of a patient-specific opioid prescribing framework for estimating postdischarge opioid consumption.

methodsA total of 149 patients were evaluated for a single-center retrospective cohort study of plastic and reconstructive surgery patients. Patients with length of stay of 2 to 8 days and quantifiable inpatient opioid consumption (n = 116) were included. Each patient's daily postoperative inpatient opioid consumption was used to generate a personalized logarithmic regression model to estimate postdischarge opioid need. The validity of the personalized opioid prescription (POP) model was tested through comparison with actual postdischarge opioid consumption reported by patients 4 weeks after surgery. The accuracy of the POP model was compared with two other opioid prescribing models.

resultsThe POP model had the strongest association (R2 = 0.899; P < 0.0001) between model output and postdischarge opioid consumption when compared to a procedure-based (R2 = 0.226; P = 0.025) or a 24-hour (R2 = 0.152; P = 0.007) model. Accuracy of the POP model was unaffected by age, gender identity, procedure type, or length of stay. Odds of persistent use at 4 weeks increased, with a postdischarge estimated opioid need at a rate of 1.16 per 37.5 oral morphine equivalents (P = 0.010; 95% CI, 1.04 to 1.30).

conclusionsThe POP model accurately estimates postdischarge opioid consumption and risk of developing persistent use in plastic surgery patients. Use of the POP model in clinical practice may lead to more appropriate and personalized opioid prescribing.

Indexed as

Analgesics, OpioidPatient DischargeAftercareDrug PrescriptionsFemaleGender IdentityHumansMalePostoperative PainPractice Patterns, Physicians'Retrospective StudiesAnalgesics, Opioid

Identifiers

PMID36696335
PMCPMC10449368

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.